BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,161,185 | -51.4% | 30,768 | -41.4% | 0.00% | -50.0% |
| Q2 2023 | $2,390,715 | +21.7% | 52,474 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $1,964,646 | -15.2% | 48,438 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $2,317,046 | -27.5% | 45,459 | -23.2% | 0.00% | -33.3% |
| Q3 2022 | $3,196,000 | -19.7% | 59,227 | -4.4% | 0.00% | -25.0% |
| Q2 2022 | $3,982,000 | -96.9% | 61,977 | -96.2% | 0.00% | -96.3% |
| Q1 2022 | $128,029,000 | +2068.1% | 1,650,719 | +2202.6% | 0.11% | +2060.0% |
| Q4 2021 | $5,905,000 | +27.9% | 71,690 | +21.8% | 0.01% | +25.0% |
| Q3 2021 | $4,618,000 | -20.8% | 58,876 | -21.7% | 0.00% | -20.0% |
| Q2 2021 | $5,832,000 | -85.3% | 75,178 | -84.1% | 0.01% | -86.8% |
| Q1 2021 | $39,646,000 | -55.2% | 471,861 | -57.2% | 0.04% | -58.7% |
| Q4 2020 | $88,528,000 | +4.2% | 1,103,718 | +4.4% | 0.09% | -8.9% |
| Q3 2020 | $84,962,000 | -4.8% | 1,056,874 | +2.0% | 0.10% | -9.0% |
| Q2 2020 | $89,222,000 | +12.2% | 1,036,646 | +5.8% | 0.11% | -8.3% |
| Q1 2020 | $79,524,000 | +178.3% | 979,490 | +186.6% | 0.12% | +266.7% |
| Q4 2019 | $28,577,000 | -48.7% | 341,746 | -46.3% | 0.03% | -51.5% |
| Q3 2019 | $55,681,000 | -11.3% | 636,572 | -17.0% | 0.07% | -9.3% |
| Q2 2019 | $62,780,000 | +58.0% | 766,538 | +56.9% | 0.08% | +53.1% |
| Q1 2019 | $39,728,000 | +171.3% | 488,603 | +119.6% | 0.05% | +145.0% |
| Q4 2018 | $14,645,000 | +262.5% | 222,505 | +324.7% | 0.02% | +300.0% |
| Q3 2018 | $4,040,000 | -38.5% | 52,397 | -40.2% | 0.01% | -28.6% |
| Q2 2018 | $6,572,000 | +55.4% | 87,563 | +37.3% | 0.01% | +40.0% |
| Q1 2018 | $4,230,000 | -4.5% | 63,798 | -4.3% | 0.01% | 0.0% |
| Q4 2017 | $4,428,000 | +26.2% | 66,630 | +19.1% | 0.01% | +25.0% |
| Q3 2017 | $3,510,000 | +9.0% | 55,935 | +5.2% | 0.00% | 0.0% |
| Q2 2017 | $3,220,000 | +23.1% | 53,180 | +5.4% | 0.00% | +33.3% |
| Q1 2017 | $2,616,000 | +25.8% | 50,441 | +7.6% | 0.00% | 0.0% |
| Q4 2016 | $2,079,000 | -10.2% | 46,876 | -3.7% | 0.00% | 0.0% |
| Q3 2016 | $2,316,000 | +192.4% | 48,665 | +177.9% | 0.00% | +200.0% |
| Q2 2016 | $792,000 | +62.0% | 17,513 | +47.2% | 0.00% | 0.0% |
| Q1 2016 | $489,000 | -0.6% | 11,894 | -7.8% | 0.00% | 0.0% |
| Q4 2015 | $492,000 | -65.5% | 12,900 | -70.3% | 0.00% | -50.0% |
| Q3 2015 | $1,426,000 | -64.9% | 43,422 | -25.3% | 0.00% | -60.0% |
| Q2 2015 | $4,067,000 | -0.5% | 58,162 | -2.5% | 0.01% | +25.0% |
| Q1 2015 | $4,086,000 | -6.0% | 59,656 | +0.6% | 0.00% | -20.0% |
| Q4 2014 | $4,346,000 | -72.5% | 59,308 | -73.1% | 0.01% | -68.8% |
| Q3 2014 | $15,802,000 | +237.3% | 220,177 | +239.8% | 0.02% | +220.0% |
| Q2 2014 | $4,685,000 | -6.9% | 64,800 | -5.2% | 0.01% | 0.0% |
| Q1 2014 | $5,030,000 | -94.7% | 68,364 | -95.0% | 0.01% | -94.8% |
| Q4 2013 | $94,564,000 | -67.7% | 1,359,650 | -70.8% | 0.10% | -44.6% |
| Q3 2013 | $293,029,000 | +63.8% | 4,652,053 | +80.1% | 0.18% | -17.8% |
| Q2 2013 | $178,879,000 | – | 2,582,350 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |